|
|
Article: Greer's Sublingual-Oral Immunotherapy Clinical Trials Support the Safety of Home Administration of Allergy Immunotherapy.
- Article from:
- PR Newswire
- Article date:
- March 6, 2006
CopyrightCOPYRIGHT 2006 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Results of Phase I Trials Announced at 2006 American Academy of Allergy Asthma and Immunology Annual Meeting
Phase III Studies Planned to Begin in Second Quarter 2006
MIAMI BEACH, Fla., March 6 /PRNewswire/ -- Greer reported results of Phase I safety and dosing trials for the sublingual-oral immunotherapy administration of its standardized dust mite, short ragweed, Timothy grass and cat hair extracts at the American Academy of Allergy Asthma and Immunology (AAAAI) annual meeting. Dr. Bob Esch, Vice President of Research and Development for Greer, presented the findings of Greer's clinical trials at the meeting, which was held March 3-7 at the Miami ...